Cargando…

Dihydrolycorine Attenuates Cardiac Fibrosis and Dysfunction by Downregulating Runx1 following Myocardial Infarction

In spite of early interventions to treat acute myocardial infarction (MI), the occurrence of adverse cardiac remodeling following heart failure due to acute MI remains a clinical challenge. Thus, there is an increasing demand for the development of novel therapeutic agents capable of inhibiting the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ni, Tingjuan, Huang, Xingxiao, Pan, Sunlei, Lu, Zhongqiu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557049/ https://www.ncbi.nlm.nih.gov/pubmed/34725565 http://dx.doi.org/10.1155/2021/8528239

Ejemplares similares

Inhibition of the long non‐coding RNA ZFAS1 attenuates ferroptosis by sponging miR‐150‐5p and activates CCND2 against diabetic cardiomyopathy
por: Ni, Tingjuan, et al.
Publicado: (2021)

Corosolic acid attenuates cardiac fibrosis following myocardial infarction in mice
por: Wang, Zhao-Peng, et al.
Publicado: (2020)

Catalpol pretreatment attenuates cardiac dysfunction following myocardial infarction in rats
por: Bi, Fangjie, et al.
Publicado: (2018)

Sotagliflozin attenuates cardiac dysfunction and remodeling in myocardial infarction rats
por: Zhong, Peng, et al.
Publicado: (2023)

Downregulation of microRNA-218 is cardioprotective against cardiac fibrosis and cardiac function impairment in myocardial infarction by binding to MITF
por: Qian, Linfeng, et al.
Publicado: (2019)

Retraction: Downregulation of microRNA-218 is cardioprotective against cardiac fibrosis and cardiac function impairment in myocardial infarction by binding to MITF
por: Qian, Linfeng, et al.
Publicado: (2021)

Runx1 Deficiency Protects Against Adverse Cardiac Remodeling After Myocardial Infarction
por: McCarroll, Charlotte S., et al.
Publicado: (2018)

Exercise training prior to myocardial infarction attenuates cardiac deterioration and cardiomyocyte dysfunction in rats
por: Bozi, Luiz Henrique Marchesi, et al.
Publicado: (2013)

Deletion of Neuropeptide Y Attenuates Cardiac Dysfunction and Apoptosis During Acute Myocardial Infarction
por: Huang, Wei, et al.
Publicado: (2019)

Downregulation of apoptotic repressor AVEN exacerbates cardiac injury after myocardial infarction
por: Yu, Peng, et al.
Publicado: (2023)

Novel Therapies for the Treatment of Cardiac Fibrosis Following Myocardial Infarction
por: Raziyeva, Kamila, et al.
Publicado: (2022)

miR-30a attenuates cardiac fibrosis in rats with myocardial infarction by inhibiting CTGF
por: Chen, Liwen, et al.
Publicado: (2018)

MicroRNA-132 attenuated cardiac fibrosis in myocardial infarction-induced heart failure rats
por: Wang, Guoyu, et al.
Publicado: (2020)

Icariin Ameliorates Diabetic Cardiomyopathy Through Apelin/Sirt3 Signalling to Improve Mitochondrial Dysfunction
por: Ni, Tingjuan, et al.
Publicado: (2020)

Senescent cardiomyocytes contribute to cardiac dysfunction following myocardial infarction
por: Redgrave, Rachael, et al.
Publicado: (2023)

Senescent cardiomyocytes contribute to cardiac dysfunction following myocardial infarction
por: Redgrave, Rachael E., et al.
Publicado: (2023)

Cathepsin B inhibition attenuates cardiac dysfunction and remodeling following myocardial infarction by inhibiting the NLRP3 pathway
por: Liu, Aiguo, et al.
Publicado: (2017)

A peptide vaccine targeting angiotensin II attenuates the cardiac dysfunction induced by myocardial infarction
por: Watanabe, Ryo, et al.
Publicado: (2017)

XPO1 Gene Therapy Attenuates Cardiac Dysfunction in Rats with Chronic Induced Myocardial Infarction
por: García-Manzanares, María, et al.
Publicado: (2019)

Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats
por: Lu, Jing, et al.
Publicado: (2012)

Downregulation of interferon-induced protein with tetratricopeptide repeats 3 relieves the inflammatory response and myocardial fibrosis of mice with myocardial infarction and improves their cardiac function
por: Sun, Jianhua, et al.
Publicado: (2021)

Targeting Immune-Fibroblast Crosstalk in Myocardial Infarction and Cardiac Fibrosis
por: Amrute, Junedh M., et al.
Publicado: (2023)

Tetrandrine attenuates left ventricular dysfunction in rats with myocardial infarction
por: Wu, Youyang, et al.
Publicado: (2021)

Senescent Cardiac Fibroblast Is Critical for Cardiac Fibrosis after Myocardial Infarction
por: Zhu, Fuli, et al.
Publicado: (2013)

Short-Duration Swimming Exercise after Myocardial Infarction Attenuates Cardiac Dysfunction and Regulates Mitochondrial Quality Control in Aged Mice
por: Zhao, Dajun, et al.
Publicado: (2018)

Cardiac fibrosis in myocardial infarction—from repair and remodeling to regeneration
por: Talman, Virpi, et al.
Publicado: (2016)

Renal Sympathetic Denervation in Rats Ameliorates Cardiac Dysfunction and Fibrosis Post-Myocardial Infarction Involving MicroRNAs
por: Zheng, Xiaoxin, et al.
Publicado: (2016)

Author Correction: Senescent cardiomyocytes contribute to cardiac dysfunction following myocardial infarction
por: Redgrave, Rachael E., et al.
Publicado: (2023)

Downregulation of microRNA-17-5p improves cardiac function after myocardial infarction via attenuation of apoptosis in endothelial cells
por: Yang, Shuo, et al.
Publicado: (2018)

The ACE2-Ang (1–7)-Mas receptor axis attenuates cardiac remodeling and fibrosis in post-myocardial infarction
por: Wang, Juan, et al.
Publicado: (2017)

Defining the timeline of periostin upregulation in cardiac fibrosis following acute myocardial infarction in mice
por: Gil, Hadas, et al.
Publicado: (2022)

Cell Therapy Attenuates Cardiac Dysfunction Post Myocardial Infarction: Effect of Timing, Routes of Injection and a Fibrin Scaffold
por: Nakamuta, Juliana S., et al.
Publicado: (2009)

Targeted NGF siRNA Delivery Attenuates Sympathetic Nerve Sprouting and Deteriorates Cardiac Dysfunction in Rats with Myocardial Infarction
por: Hu, Hesheng, et al.
Publicado: (2014)

Lactoferrin attenuates cardiac fibrosis and cardiac remodeling after myocardial infarction via inhibiting mTORC1/S6K signaling pathway
por: Ye, Tianbao, et al.
Publicado: (2023)

Sacubitril/Valsartan Improves Cardiac Function and Decreases Myocardial Fibrosis Via Downregulation of Exosomal miR‐181a in a Rodent Chronic Myocardial Infarction Model
por: Vaskova, Evgeniya, et al.
Publicado: (2020)

MicroRNA-24 regulates cardiac fibrosis after myocardial infarction
por: Wang, Jue, et al.
Publicado: (2012)

Roselle attenuates cardiac hypertrophy after myocardial infarction in vivo and in vitro
por: Si, Lislivia-Yiang-Nee, et al.
Publicado: (2019)

Aging Attenuates Cardiac Contractility and Affects Therapeutic Consequences for Myocardial Infarction
por: Dong, Ming, et al.
Publicado: (2020)

Pigment epithelium-derived factor attenuates myocardial fibrosis via inhibiting Endothelial-to-Mesenchymal Transition in rats with acute myocardial infarction
por: Zhang, Hao, et al.
Publicado: (2017)

SGLT2 promotes cardiac fibrosis following myocardial infarction and is regulated by miR-141
por: Li, Gang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_buk3c8dd6jsuf1795at3bh5mji